Daily Trade

Don’t miss these top money and investing features: Sign up here to get MarketWatch’s best mutual funds and ETF stories emailed to you weekly! INVESTING NEWS & TRENDS Welcome to Generation Z’s first bear market Up until recently, young people’s primary experience of the market was that stocks almost always go up Read More The Dow
0 Comments
Big box retailers and department stores take center stage and report earnings next week. The biggest retailers in the world are lined up to issue their results for the first quarter (Q1) of this year. Could the results sway jittery markets? Strong earnings from major companies have not managed to pull stock markets out of
0 Comments
Labor costs are driving up inflation. But will inflation also drive more people back to the workforce? The annual rate of inflation slowed to 8.3% in April from 8.5% the previous month, helped by a fall in gasoline prices, but consumers still face rapidly rising costs. The March reading was the highest since 1981. The
0 Comments
Upstart (NASDAQ:UPST) stock lost over half its value in a single day after cutting its full-year revenue outlook The company is growing revenue and income at a fast clip despite economic headwinds UPST stock is a bargain, but that doesn’t mean shares will move higher Source: Postmodern Studio / Shutterstock.com I bought the dip in
0 Comments
Roblox Corporation (NYSE:RBLX) is on the run again. After plummeting from a high of $141.60 to a low of $21.65, the gaming stock appears to have bottomed out. It’s also starting to pivot higher from oversold relative strength, moving average convergence divergence, and Williams %R. Even better, the stock is shrugging off its latest earnings
0 Comments
The critical takeaway from the recent annual meeting of Berkshire Hathaway BRK.A, -1.36% BRK.B, -1.12% has been the least reported: the shareholder base has changed radically and the only way to assure that Berkshire endures beyond Warren Buffett is for his controlling stake be preserved after he leaves the scene.  Buffett spent his life cultivating a high-quality
0 Comments
TOKYO—Japanese technology investor SoftBank Group Corp. on Thursday reported the biggest annual loss in its four-decade history because of the global selloff in technology shares. SoftBank 9984, -8.03%, known for its $100 billion Vision Fund, reported a net loss of ¥1.71 trillion, equivalent to $13.2 billion, for the year that ended March 31. That was
0 Comments
Biotech stocks have been through an extended lean patch, making them ideal candidates for a strong rebound. Verrica (VRCA): Approval of its viral skin disease treatment could transform the company into a commercial-stage biopharma. Amicus (FOLD): Pompe disease treatment approval opens up huge market opportunity for the biopharma. Athersys (ATHX): Potential approval for Japanese licensee
0 Comments
Novavax’s Covid-19 vaccine still isn’t approved for use in the U.S. With the pandemic in full retreat and the majority of people now fully vaccinated, demand for Novavax’s vaccine is likely to be weak. Rival pharmaceutical companies Pfizer and Moderna have beat Novavax to market with multiple Covid-19 treatments. Source: rarrarorro / Shutterstock.com Any hope
0 Comments